Abstract: The composition for oral administration of testosterone to a man who has androgen deficiency and exhibits one or more symptoms of androgen deficiency, comprises testosterone and a mixture of soybean oil and ethanol. Preferably, a pharmaceutically acceptable preservative, such as benzyl alcohol, is included in the composition. The mixture of soybean oil and ethanol is present in the composition in an amount such that when the composition is orally ingested by the testosterone is absorbed and one or more of the symptoms of androgen deficiency is ameliorated. The composition is charged into hard or soft gelatin capsules to produce orally administrable unit dosage forms.

Abstract: The composition for oral administration of testosterone to a man who has androgen deficiency and exhibits one or more symptoms of androgen deficiency, comprises testosterone and a mixture of soybean oil and ethanol. Preferably, a pharmaceutically acceptable preservative, such as benzyl alcohol, is included in the composition. The mixture of soybean oil and ethanol is present in the composition in an amount such that when the composition is orally ingested by the testosterone is absorbed and one or more of the symptoms of androgen deficiency is ameliorated. The composition is charged into hard or soft gelatin capsules to produce orally administrable unit dosage forms.

Abstract: An implant device comprises a tubular member having a bore, a charging end and a pointed elongated annular concavely beveled implanting end. A rod is removably insertable within the bore for delivery of an implant dosage form charged within the bore. A stop member for hindering movement of the rod sufficiently to prevent unintentional delivery of the implant dosage form but not sufficient to prevent same when delivery is intended is mounted on the tubular member. A truncated cylindrical solid shaped implant dosage form having an ellipsoidal face is positioned in the bore at the implanting end in alignment with same so that a substantially continuous elipsoidal surface is presented.

Abstract: An implant device comprises a tubular member having a bore, a charging end and a pointed elongated annular concavely beveled implanting end. A rod is removably insertable within the bore for delivery of an implant dosage form charged within the bore. A stop member for hindering movement of the rod sufficiently to prevent unintentional delivery of the implant dosage form but not sufficient to prevent same when delivery is intended is mounted on the tubular member. A truncated cylindrical solid shaped implant dosage form having an ellipsoidal face is positioned in the bore at the implanting end in alignment with same so that a substantially continuous elipsoidal surface is presented.